Democratic Republic of the Congo
Tuberculosis profile
| High TB burden | High HIV burden | High MDR-TB burden |
Population  2012 66 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 36 (16–64) 54 (24–97)
Mortality (HIV+TB only) 6.3 (5.5–8.1) 9.7 (8.3–12)
Prevalence  (includes HIV+TB) 380 (200–620) 576 (301–938)
Incidence  (includes HIV+TB) 210 (190–250) 327 (282–375)
Incidence (HIV+TB only) 16 (14–19) 25 (22–29)
Case detection, all forms (%) 51 (44–59)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 71 124 (68) Relapse 3 977 (53)
Smear-negative 13 214 (13) Treatment after failure 597 (8)
Smear-unknown / not done     Treatment after default 597 (8)
Extrapulmonary 20 669 (20) Other 2 321 (31)
Other          
Total new 105 007   Total retreatment 7 492  
           
Other (history unknown)          
Total new and relapse 108 984   Total cases notified 112 499  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.3    
Age < 15 3 138 3 080 7 347
Laboratories 2012
Smear (per 100 000 population) 2.3
Culture (per 5 million population) 0.3
Drug susceptibility testing (per 5 million population) 0.2
Is second-line drug susceptibility testing available? Yes, in and outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 87   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 89  
Retreatment 74  
TB/HIV 2012 Number (%)
TB patients with known HIV status 35 097 (31)
HIV-positive TB patients 5 748 (16)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 3 485 (61)
HIV-positive TB patients on antiretroviral therapy (ART) 2 296 (40)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.5 (0.01–5) 10 (3.5–17)
MDR-TB cases among notified pulmonary
TB cases
2 100 (8–4 200) 760 (260–1 300)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 12 (<1%) 95 (1%) 109
Laboratory-confirmed MDR-TB cases 5 59 81
Patients started on MDR-TB treatment     262
Financing TB control 2013
National TB programme budget (US$ millions) 61
% Funded domestically 1%
% Funded internationally 25%
% Unfunded 74%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-19 Data: www.who.int/tb/data